DrugBank 5.0: a major update to the DrugBank database for 2018
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
DrugBank (www.drugbank.ca) is a web-enabled database containing comprehensive molecular information about drugs, their mechanisms, their interactions and their targets. First described in 2006, DrugBank has continued to evolve over the past 12 years in response to marked improvements to web standards and changing needs for drug research and development. This year's update, DrugBank 5.0, represents the most significant upgrade to the database in more than 10 years. In many cases, existing data content has grown by 100% or more over the last update. For instance, the total number of investigational drugs in the database has grown by almost 300%, the number of drug-drug interactions has grown by nearly 600% and the number of SNP-associated drug effects has grown more than 3000%. Significant improvements have been made to the quantity, quality and consistency of drug indications, drug binding data as well as drug-drug and drug-food interactions. A great deal of brand new data have also been added to DrugBank 5.0. This includes information on the influence of hundreds of drugs on metabolite levels (pharmacometabolomics), gene expression levels (pharmacotranscriptomics) and protein expression levels (pharmacoprotoemics). New data have also been added on the status of hundreds of new drug clinical trials and existing drug repurposing trials. Many other important improvements in the content, interface and performance of the DrugBank website have been made and these should greatly enhance its ease of use, utility and potential applications in many areas of pharmacological research, pharmaceutical science and drug education.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DrugBank primarily contains drug indications extracted from drug labels, while MEDI utilizes public internet sources to drug indications, and is a well utilized resource of drug indications.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Finally, we searched DrugBank84 to identify therapeutic compounds targeting AD-associated proteins. Of the 38 proteins, 15 had reported molecules (Fig. 4D).”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [84]
In the citing paper
“AVPR2 and NPR1 genes play pivotal roles in regulating fluid and electrolyte balance via complementary but distinct pathways. AVPR2 contributes to water retention and urine concentration, whereas NPR1 facilitates vasodilatation, lowers blood pressure and enhances water excretion47.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [47]
In the citing paper
“In essence, the CC is an alternative representation of the small-molecule knowledge deposited in the public domain and, as such, it is also limited by the availability of experimental data and the coverage of its source databases (e.g., ChEMBL9 or DrugBank10).”
From Bioactivity descriptors for uncharacterized chemical compounds (2021) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892 · cited 1×
“DrugBank 1.0, released in 2006, provided novel (at the time) physico-chemical data on selected FDA-approved drugs and their drug-targets (2).”
BackgroundInfluentialSelf-citationDrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861 · cited 1×
“DrugBank 2.0, released in 2008, added pharmacological, pharmacogenomic and molecular biological data (3).”
BackgroundInfluentialSelf-citationThe new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
MacArthur, J., Bowler, E., Cerezo, M., Gil, L., Hall, P., Hastings, E., Junkins, H., McMahon, A., Milano, A., Morales, J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1133 · Cited by 2,161 · cited 2×
“org and FDA labels), as well as material collated from sources such as The Human Cytochrome P450 (CYP) Allele Nomenclature Database (12) and the NHGRI-EBI GWAS Catalog (13).”
BackgroundDrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,993 · cited 1×
“tion, distribution, metabolism, excretion and toxicity) data (5).”
Self-citationDrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831 · cited 1×
“DrugBank 3.0, released in 2010, added drug–drug and drug–food interactions, drug transporter data as well as pharmacokinetic information (4).”
BackgroundInfluentialSelf-citationClassyFire: automated chemical classification with a comprehensive, computable taxonomy
Djoumbou Feunang, Y., Eisner, R., Knox, C., Chepelev, L., Hastings, J., Owen, G., Fahy, E., Steinbeck, C., Subramanian, S., Bolton, E., et al. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0174-y · Cited by 1,525
Self-citationThe Comparative Toxicogenomics Database: update 2017
Davis, A. P., Grondin, C. J., Johnson, R. J., Sciaky, D., King, B. L., McMorran, R., Wiegers, J., Wiegers, T. C., & Mattingly, C. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw838 · Cited by 544 · cited 1×
“Additional pharmacoproteomic and pharmacotranscriptomic data were obtained from the CTD (18).”
MethodPredicting drug metabolism: experiment and/or computation?
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4581 · Cited by 502 · cited 1×
“It has also become much more robust and sophisticated (21).”
BackgroundAllen, F., Pon, A., Wilson, M., Greiner, R., & Wishart, D. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku436 · Cited by 464 · cited 7×
“In particular, CFM-ID (19) and CFM-ID 2.”
BackgroundInfluentialSelf-citationSim, S. C., & Ingelman-Sundberg, M. (2010) · Human Genomics · doi:10.1186/1479-7364-4-4-278 · Cited by 216 · cited 2×
“org and FDA labels), as well as material collated from sources such as The Human Cytochrome P450 (CYP) Allele Nomenclature Database (12) and the NHGRI-EBI GWAS Catalog (13).”
Background
Cited by
Items 801–900 of 1,056
Predicting Anticancer Drug Response With Deep Learning Constrained by Signaling Pathways
Zhang, H., Chen, Y., & Li, F. (2021) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2021.639349 · Cited by 57
“The drug target information was derived from DrugBank database; and 24 out of the 54 drugs were selected for this study, whose target genes are on the 46 signaling pathways (see Table 2 ).”
BackgroundA novel graph attention model for predicting frequencies of drug–side effects from multi-view data
Zhao, H., Zheng, K., Li, Y., & Wang, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab239 · Cited by 65
Identification of Drug-Disease Associations by Using Multiple Drug and Disease Networks
Yang, Y., & Chen, L. (2021) · Current Bioinformatics · doi:10.2174/1574893616666210825115406 · Cited by 62
SmileGNN: Drug–Drug Interaction Prediction Based on the SMILES and Graph Neural Network
Han, X., Xie, R., Li, X., & Li, J. (2022) · Life · doi:10.3390/life12020319 · Cited by 63
“One of the main data sources for this paper is DrugBank [18].”
BackgroundIschemic stroke: From pathological mechanisms to neuroprotective strategies
Jiang, Y., Liu, Z., Liao, Y., Sun, S., Dai, Y., & Tang, Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1013083 · Cited by 63
“In addition, two clinical trials registered with acetylcysteine treating IS, are still ongoing (114).”
BackgroundRen, Z.-H., You, Z., Zou, Q., Yu, C.-Q., Ma, Y., Guan, Y.-J., You, H.-R., Wang, X., & Pan, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03876-3 · Cited by 61
“According to the type of protein, the dataset can be divided into four main datasets containing enzymes, G-protein-coupled receptors (GPCR), ion channels and nuclear receptors, which have been collected from DrugBank [16], BRENDA [47], KEGG ERITE [48] and Super-Target [49].”
MethodPolycystic ovary syndrome: Current scenario and future insights
Kulkarni, S., Gupta, K. A., Ratre, P., Mishra, P. K., Singh, Y., Biharee, A., & Thareja, S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103821 · Cited by 68
DMFDDI: deep multimodal fusion for drug–drug interaction prediction
Gan, Y., Liu, W., Xu, G., Yan, C., & Zou, G. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad397 · Cited by 63
“Meanwhile, to integrate different biochemical feature similarities of drugs into DMFDDI, we obtain and combine the required biochemical feature data from well-known databases, including DrugBank [35] and KEGG [36].”
MethodSu, X., Hu, P., You, Z., Yu, P. S., & Hu, L. (2024) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v38i1.27777 · Cited by 60
“We evaluate the TIGER on three benchmark drug-related heterogeneous graph datasets, i.e., DrugBank (Wishart et al. 2018), KEGG (Kanehisa et al. 2017), and OGB-biokg (Hu et al. 2020), with different scales for verifying the scalability and robustness of TIGER.”
MethodHaring, M., Balanna, K., Cheng, Q., Lammert, J., & Studer, A. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c11759 · Cited by 58
Ruyle, B. J., Pennoyer, E. H., Vojta, Š., Bečanová, J., Islam, M., Webster, T. F., Heiger‐Bernays, W., Lohmann, R., Westerhoff, P. K., Schaefer, C. E., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417156122 · Cited by 63
ExonSkipDB: functional annotation of exon skipping event in human
Kim, P., Yang, M., Yiya, K., Zhao, W., & Zhou, X. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz917 · Cited by 69
Current computational methods for predicting protein interactions of natural products
Moumbock, A. F. A., Li, J., Mishra, P., Gao, M., & Günther, S. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.08.008 · Cited by 62
Nickel-Catalyzed Direct Acylation of Aryl and Alkyl Bromides with Acylimidazoles
Zhuo, J., Zhang, Y., Li, Z., & Li, C. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c00246 · Cited by 58
Self-citationMa, T., Zhang, G.-L., Dai, C.-F., Zhang, B.-R., Cao, K., Wang, C., Yang, G., & Wang, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112929 · Cited by 63
The application of machine learning techniques to innovative antibacterial discovery and development
Serafim, M. S. M., Kronenberger, T., Oliveira, P. R., Poso, A., Honório, K. M., Mota, B. E. F., & Maltarollo, V. G. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1776696 · Cited by 63
Ma, X., Yu, M., Hao, C., & Yang, W. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113059 · Cited by 59
Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure
Liu, A., Walter, M., Wright, P. S. R., Bartosik, A., Dolciami, D., Elbasir, A., Yang, H., & Bender, A. (2021) · Biology Direct · doi:10.1186/s13062-020-00285-0 · Cited by 61
Deluigi, M., Klipp, A., Klenk, C., Merklinger, L., Eberle, S. A., Morstein, L., Heine, P., Mittl, P. R. E., Erñst, P., Kamenecka, T. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe5504 · Cited by 58
Cui, C., Ding, X., Wang, D., Chen, L., Xiao, F., Xu, T., Zheng, M., Luo, X., Jiang, H., & Chen, K. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab191 · Cited by 60
Machine learning and network medicine approaches for drug repositioning for COVID-19
Santos, S. D. S., Torres, M., Galeano, D., Sánchez, M. D. M., Cernuzzi, L., & Paccanaro, A. (2021) · Patterns · doi:10.1016/j.patter.2021.100396 · Cited by 59
“With this approach we ranked 2,197 approved drugs from DrugBank.(47) We used the types of evidence described above to create three datasets where drugs were classified as either effective or non-effective for COVID-19 (see experimental procedures).”
InfluentialArtificial neural networks enable genome-scale simulations of intracellular signaling
Nilsson, A., Peters, J. M., Meimetis, N., Bryson, B. D., & Lauffenburger, D. A. (2022) · Nature Communications · doi:10.1038/s41467-022-30684-y · Cited by 66
Chaves, M. D. J. S., Kulzer, J., de Lima, P. D. R. P., Caldas, S. S., & Prímel, E. G. (2022) · Environmental Science Processes & Impacts · doi:10.1039/d2em00132b · Cited by 68
Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model
Brai, A., Poggialini, F., Vagaggini, C., Pasqualini, C., Simoni, S., Francardi, V., & Dreassi, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032296 · Cited by 63
“) administrations were compared to obtained data [23,24], showing good correlation (Figure 3).”
MethodResultA proteogenomics data-driven knowledge base of human cancer
Liao, Y., Savage, S. R., Dou, Y., Shi, Z., Yi, X., Jiang, W., Lei, J. T., & Zhang, B. (2023) · Cell Systems · doi:10.1016/j.cels.2023.07.007 · Cited by 67
Selvaraj, G., Kaliamurthi, S., Kaushik, A. C., Khan, A., Wei, Y.-K., Cho, W. C. S., Gu, K., & Wei, D. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.09.004 · Cited by 62
The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond
Devchand, P. R., Liu, T., Altman, R. B., FitzGerald, G. A., & Schadt, E. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01093 · Cited by 54
Global landscape of mouse and human cytokine transcriptional regulation
Pro, S. C., Imedio, A. D., Santoso, C., Gan, K. A., Sewell, J. A., Martinez, M., Sereda, R., Mehta, S. M., & Bass, J. I. F. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky787 · Cited by 60
Wang, X., Gong, L., Huang, J., Jiang, C., & Yan, Z. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173212 · Cited by 59
Computational Approaches for De Novo Drug Design: Past, Present, and Future
Liu, X., Ijzerman, A., & van Westen, G. V. (2021) · Artificial Neural Networks, 3rd Edition · doi:10.1007/978-1-0716-0826-5_6 · Cited by 35
Prediction of drug metabolites using neural machine translation
Litsa, E. E., Das, P., & Kavraki, L. E. (2020) · Chemical Science · doi:10.1039/d0sc02639e · Cited by 63
“The added drug molecules were manually chosen from DrugBank in an effort to create a more diverse test set in terms of metabolizing enzymes.”
MethodInfluentialAbdel‐Basset, M., Hawash, H., Elhoseny, M., Chakrabortty, R. K., & Ryan, M. J. (2020) · IEEE Access · doi:10.1109/access.2020.3024238 · Cited by 62
Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics
Lemus, E. H., & Martínez-García, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.605680 · Cited by 61
“Pathway deregulation metrics will allow for further fi ltering via joint analysis of pathway deregulation, differential gene expression, drug-target interactions, off-target, and side effects databases such as PharmGKB (65, 66), DrugBank (67), the Therapeutic Target Database, TTD (68) and others.”
BackgroundZheng, K., Lv, B., Wu, L., Wang, C., Xu, H., Li, X., Wu, Z., Zhao, Y., & Zheng, Z. (2022) · Bioengineered · doi:10.1080/21655979.2022.2052671 · Cited by 58
DockCoV2: a drug database against SARS-CoV-2
Chen, T.-F., Chang, Y., Hsiao, Y., Lee, K.-H., Hsiao, Y.-C., Lin, Y.-H., Tu, Y.-C. E., Huang, H., Chen, C., & Juan, H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa861 · Cited by 58
The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation
Ke, J., Li, M., Huo, Y., Cheng, Y., Guo, S., Wu, Y., Zhang, L., Ma, J., Liu, A., & Han, Y. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s318515 · Cited by 57
NCATS Inxight Drugs: a comprehensive and curated portal for translational research
Siramshetty, V. B., Grishagin, I. V., Nguyễn, Ð.-T., Peryea, T., Skovpen, Y., Stroganov, O. V., Katzel, D. A., Sheils, T. K., Jadhav, A., Mathé, E. A., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab918 · Cited by 64
Artificial intelligence and machine learning in pain research: a data scientometric analysis
Lötsch, J., Ultsch, A., Mayer, B., & Kringel, D. (2022) · PAIN Reports · doi:10.1097/pr9.0000000000001044 · Cited by 66
“For example, functional genomics-based drug discovery 51 using the Gene Ontology knowledge base 2 at https://www.geneontology.org/ combined with the DrugBank database 94 at https://go.drugbank. com.”
Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis
Singh, M., Venugopal, C., Tokár, T., McFarlane, N., Subapanditha, M., Qazi, M. A., Bakhshinyan, D., Vora, P., Murty, N. K., Jurišica, I., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1022 · Cited by 60
Venema, W. T. U., Voskuil, M. D., Vila, A. V., van der Vries, G. B., Jansen, B. H., Jabrì, B., Faber, K. N., Dijkstra, G. D. H., Xavier, R. J., Wijmenga, C., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.046 · Cited by 59
Intensified antibiotic treatment of tuberculosis meningitis
Cresswell, F. V., Brake, L. T., Atherton, R. R., Ruslami, R., Dooley, K. E., Aarnoutse, R. E., & van Crevel, R. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1552831 · Cited by 59
Drug design targeting active posttranslational modification protein isoforms
Meng, F., Liang, Z. T., Zhao, K., & Luo, C. (2020) · Medicinal Research Reviews · doi:10.1002/med.21774 · Cited by 61
Khan, A., Rehman, Z., Hashmi, H. F., Khan, A. A., Junaid, M., Sayaf, A. M., Ali, S. S., Hassan, F., Heng, W., & Wei, D. (2020) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-020-00360-0 · Cited by 55
“The data entry of each drug contains sufficient information (about 200 in each case) on drug chemical nature and their target [20].”
BackgroundMarmon, P., Owen, S. F., & Margiotta‐Casaluci, L. (2020) · Environment International · doi:10.1016/j.envint.2020.106222 · Cited by 61
Dong, X., Deng, J., Hou, W., Rashidian, S., Abell-Hart, K., Rosenthal, R. N., Saltz, J. H., Saltz, J., & Wang, F. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103725 · Cited by 64
MitoTox: a comprehensive mitochondrial toxicity database
Lin, Y.-T., Lin, K., Huang, C., & Wei, A. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04285-3 · Cited by 64
Zhang, B., Hao, Z., Zhou, W., Zhang, S., Sun, M., Li, H., Hou, N., Jing, C., & Zhao, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.1959493 · Cited by 57
Hindy, G., Dornbos, P., Chaffin, M. D., Liu, D. J., Wang, M., Selvaraj, M. S., Zhang, D., Park, J., Aguilar-Salinas, C. A., Fulton, L., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.11.021 · Cited by 83
Causal effects of inflammatory protein biomarkers on inflammatory diseases
Ek, W. E., Karlsson, T., Höglund, J., Rask‐Andersen, M., & Johansson, Å. (2021) · Science Advances · doi:10.1126/sciadv.abl4359 · Cited by 59
“TNF signaling is a therapeutic target for inflammatory disease, and more than 20 agents that target the TNF-signaling pathway are currently in clinical use ( 18 , 19 ).”
BackgroundLi, X., Ren, J. F., Zhang, W., Zhang, Z., Yu, J., Wu, J., Sun, H., Zhou, S., Yan, K., Yan, X., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106185 · Cited by 62
Ahmad, S., Mussuvir Pasha, K. M., Raza, K., Rafeeq, M. M., Habib, A. H., Eswaran, M., & Yadav, M. K. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2060308 · Cited by 61
“The downloaded DrugBank structure data were imported into the workspace and used LigPrep wizard for preparing the ligands (Release, 2017; Wishart et al., 2018).”
MethodSPASCER: spatial transcriptomics annotation at single-cell resolution
Fan, Z., Luo, Y., Lu, H., Wang, T., Feng, Y., Zhao, W., Kim, P., & Zhou, X. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac889 · Cited by 57
Ge, Y., Ou, Y., Deng, Y., Wu, B., Liu, Y., Zhang, Y.-R., Chen, S.-D., Huang, Y., Dong, Q., Tan, L., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.002 · Cited by 56
Self-citationArtificial Intelligence and Data Mining for the Pharmacovigilance of Drug–Drug Interactions
Hauben, M. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.01.002 · Cited by 65
P38 kinase in gastrointestinal cancers
Phan, T. X., Zhang, X. H., Rosen, S. T., & Melstrom, L. G. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00622-1 · Cited by 59
“Based on the Drugbank platform, several p38γ-targeted drugs including phosphonothreonine, phosphoamino phosphonicacid-adenylate ester, CEP-1347 and KC706 are being investigated and tested [83, 84].”
BackgroundPharmBERT: a domain-specific BERT model for drug labels
ValizadehAslani, T., Shi, Y., Ren, P., Wang, J., Zhang, Y., Hu, M., Zhao, L., & Liang, H. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad226 · Cited by 50
A survey on semantic processing techniques
Mao, R., He, K., Zhang, X., Chen, G., Ni, J., Yang, Z., & Cambria, E. (2023) · Information Fusion · doi:10.1016/j.inffus.2023.101988 · Cited by 72
Leveraging machine learning models for peptide–protein interaction prediction
Song, Y., Mi, X., & Shukla, D. (2024) · RSC Chemical Biology · doi:10.1039/d3cb00208j · Cited by 65
Seal, S., Spjuth, O., Hosseini-Gerami, L., García-Ortegón, M., Singh, S., Bender, A., & Carpenter, A. E. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01834 · Cited by 58
Muthuramalingam, P., Jeyasri, R., Varadharajan, V., Priya, A., Dhanapal, A. R., Shin, H., Thiruvengadam, M., Ramesh, M., Krishnan, M., Omosimua, R. O., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1410942 · Cited by 59
“Additionally, compound and drug detail databases such as PubChem, Drugbank (Wishart et al., 2018), ChEMBL (Gaulton et al., 2012), and STITCH (Kuhn et al., 2014), target interaction databases such as Reactome (Matthews et al., 2009), MINT (Zanzoni et al., 2002), STRING (Szklarczyk et al., 2015), HAPPI (Chen et al., 200…”
BackgroundGenes with High Network Connectivity Are Enriched for Disease Heritability
Kim, S. S., Dai, C., Hormozdiari, F., van de Geijn, B., Gazal, S., Park, Y., O’Connor, L., Amariuta, T., Loh, P.-R., Finucane, H., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.03.020 · Cited by 57
Using OmicsNet for Network Integration and 3D Visualization
Zhou, G., & Xia, J. (2018) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.69 · Cited by 61
Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics
Pérez‐Pérez, M., Rodríguez, G. P., Fdez‐Riverola, F., & Lourenço, A. M. G. (2019) · Journal of Medical Internet Research · doi:10.2196/12610 · Cited by 58
Mou, X., Zhou, D., Zhou, D., Liu, K., Chen, L. J., & Liu, W. H. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153192 · Cited by 64
Dai, Y., Qiang, W., Yu, X., Cai, S., Lin, K., Xie, L., Lan, X., & Wang, D. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.05.004 · Cited by 57
“4, updated on July 2nd, 2019) [20], and the TTD (http://bidd.”
BackgroundFeature selection strategies for drug sensitivity prediction
Koras, K., Juraeva, D., Kreis, J., Mazur, J., Staub, E., & Szczurek, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-65927-9 · Cited by 62
Xu, C., Ke, Z., Liu, C., Wang, Z., Liu, D., Zhang, L., Wang, J., He, W., Xu, Z., Li, Y., et al. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00821 · Cited by 55
Advances in Genomics for Drug Development
Spreafico, R., Soriaga, L. B., Grosse, J., Virgin, H. W., & Telenti, A. (2020) · Genes · doi:10.3390/genes11080942 · Cited by 59
“Open-source and commercial resources such as OpenTargets [100], DGIdb [101], ChEMBL [102], GuideToPharmacology [103], Drugbank [104], Clarivate Integrity, GVK Excelra GoStar, and Citeline Pharmaprojects, which map clinical-stage drugs and active compounds to target human proteins, facilitate gene-to-drug validation wo…”
BackgroundDrug–drug similarity measure and its applications
Huang, L., Luo, H., Li, S., Wu, F., & Wang, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa265 · Cited by 66
Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies
Han, N., Hwang, W., Tzelepis, K., Schmerer, P., Yankova, E., MacMahon, M., Lei, W., Katritsis, N. M., Liu, A., Felgenhauer, U., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh3032 · Cited by 60
“Approved drugs were collected from ChEMBL ( 16 ) and DrugBank ( 17 ).”
BackgroundMethodA data-driven approach for predicting the impact of drugs on the human microbiome
Algavi, Y. M., & Borenstein, E. (2023) · Nature Communications · doi:10.1038/s41467-023-39264-0 · Cited by 54
Yang, S., Chen, F., Lian, X., Dong, X., & Zhang, Z. (2019) · mSystems · doi:10.1128/msystems.00303-18 · Cited by 60
Wu, Z., Peng, Y., Yu, Z., Li, W., Liu, G., & Tang, Y. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00291 · Cited by 64
The relevant targets of anti-oxidative stress: a review
Qi, J., & Dong, F.-X. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2020.1870987 · Cited by 56
“Clinical medication NADPH oxidase Ecabet Reflux oesophagitis; Peptic ulcer disease Clinical medication [63]”
BackgroundPharmacotherapeutic Strategies and New Targets in OCD
Pittenger, C. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_204 · Cited by 59
Lipid metabolism in asthma: Immune regulation and potential therapeutic target
Li, W., Zhao, Y. F., Gao, Y., Dong, L., Wu, Y., Chen, Z., & Shen, H. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104341 · Cited by 60
Liu, Z., Liu, J., Liu, X., Wang, X., Xie, Q., Zhang, X., Kong, X., He, M., Yang, Y., Deng, X., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab860 · Cited by 74
“Drugs were harmonized by the IDs and names of Drug-Bank (27), ChEMBL (28) and PubChem (29).”
Self-citationRole of surfactants in improving release from higher drug loading amorphous solid dispersions
Correa-Soto, C. E., Gao, Y., Indulkar, A. S., Zhang, G. G. Z., & Taylor, L. S. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122120 · Cited by 55
Circulating Proteins Influencing Psychiatric Disease: A Mendelian Randomization Study
Lu, T., Forgetta, V., Greenwood, C. M. T., Zhou, S., & Richards, J. B. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.08.015 · Cited by 66
Solimando, A. G., Desantis, V., & Ribatti, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214004 · Cited by 62
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation
Zhou, J., Tang, D., He, L., Lin, S., Lei, J. H., Sun, H., Xu, X., & Deng, C. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106830 · Cited by 57
Shilpa, S., Kashyap, G., & Sunoj, R. B. (2023) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.3c04779 · Cited by 61
Jing, Z., Che, C., Jiang, H., Xu, J., Yin, J., & Zhong, Z. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05654-4 · Cited by 64
“DrugBank contains bioinformatics, chemoinformatics, and other resources incorporating detailed drug data [34], covering 86 different interaction types and describing how one drug affects the metabolism of other drugs.”
BackgroundMapping the perturbome network of cellular perturbations
Caldera, M., Müller, F., Kaltenbrunner, I., Licciardello, M. P., Lardeau, C.-H., Kubicek, S., & Menche, J. (2019) · Nature Communications · doi:10.1038/s41467-019-13058-9 · Cited by 59
Liu, H., Zhang, W., Song, Y., Deng, L., & Zhou, S. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b01008 · Cited by 56
MASI: microbiota—active substance interactions database
Zeng, X. L., Yang, X., Fan, J., Tan, Y. C., Ju, L., Shen, W. X., Wang, Y., Wang, X., Chen, W., Ju, D., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa924 · Cited by 54
“The Anatomical Therapeutic Chemical Classification System (ATC) codes of the drugs were from DrugBank database (25) by matching DrugBank identifiers or PubChem CID identifiers with those in the DrugBank records.”
BackgroundMethodPrediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning
Rajput, A., Thakur, A., Mukhopadhyay, A., Kamboj, S., Rastogi, A., Gautam, S., Jassal, H., & Kumar, M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.037 · Cited by 55
Zhang, S., Lu, Y., Chen, W., Shi, W. Q., Zhao, Q., Zhao, J., & Li, L. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s315060 · Cited by 57
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes
Tang, M., Zhao, Y., Zhao, J., Wei, S., Liu, M., Zheng, N., Geng, D., Han, S., Zhang, Y., Zhong, G., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn5683 · Cited by 61
“We analyzed the expression of 2892 drug targets documented by DrugBank ( 49 ).”
Zolotareva, O. I., Saik, O., Königs, C., Bragina, E. Y., Goncharova, I. A., Freidin, M. B., Dosenko, V., Иванисенко, В. А., & Hofestädt, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-52762-w · Cited by 59
Ibrahim, M. A. A., Abdelrahman, A. H. M., & Hegazy, M. F. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1791958 · Cited by 56
“DB02388, the imidazole-pyrimidine compound, is an investigational drug developed for the treatment of neurological disorders via inhibition mitogenactivated protein kinase 10 (MAPK10, known as c-Jun N-terminal kinase 3(JNK3))(Scapin et al., 2003; Wishart et al., 2006, 2018).”
BackgroundMethodInfluentialFeng, C., Zhao, M., Jiang, L., Hu, Z., & Fan, X. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6680637 · Cited by 59
“(e disease targets of knee osteoarthritis were summarized in GeneCards, OMIM, PharmGkb, TTD, and DrugBank databases.”
MethodChemotaxonomic investigation of plant terpenoids with an established database (TeroMOL)
Zeng, T., Chen, Y., Jian, Y., Zhang, F., & Wu, R. (2022) · New Phytologist · doi:10.1111/nph.18133 · Cited by 53
Periwal, V., Bassler, S. O., Andrejev, S., Gabrielli, N., Patil, K. R., Typas, A., & Patil, K. R. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010029 · Cited by 57
“This compound is in clinical trial (DrugBank id: DB12779) and has been patented for various therapeutic applications (Fig 2B, highlighted in purple).”
BackgroundInfluentialWang, B., Zhou, W., Zhang, H., Wang, W., Zhang, B., & Li, S. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115930 · Cited by 59
Fan, X., Zhang, Y., Song, Y., Zhao, Y., Xu, Y., Guo, F., Shao, M., Ma, X., Zhang, W., Wei, F., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154656 · Cited by 54
Su, Y., Bai, Q., Tao, H., & Xu, B. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12541 · Cited by 58
Wang, C., Yang, C., Western, D., Ali, M., Wang, Y., Phuah, C., Budde, J., Wang, L., Gorijala, P., Timsina, J., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01973-7 · Cited by 57
An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals
Détaille, D., Pasdois, P., Sémont, A., Santos, P. D. D., & Diolez, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216385 · Cited by 55
“It is also indicated as an adjunctive therapy for cholecystitis, gallstone, indigestion, and acute/chronic hepatitis (see DrugBank database [31]).”
BackgroundResultInfluentialA comprehensive overview of oncogenic pathways in human cancer
Li, F., Wu, T., Xu, Y., Dong, Q., Xiao, J., Xu, Y., Li, Q., Zhang, C., Gao, J., Liu, L., et al. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz046 · Cited by 61
Metadata
- Authors
- Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., Pon, A., Knox, C., & Wilson, M.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Wishart, David S
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-08
- Volume
- 46
- Issue
- D1
- Pages
- D1074-D1082
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC5753335
- OpenAlex
- W2767891136
- Cited by
- 8,404
- References
- 22
- Citations by year
- 2026: 617 · 2025: 929 · 2024: 1327 · 2023: 1363 · 2022: 1322 · 2021: 1175 · 2020: 957 · 2019: 502 · 2018: 201 · 2017: 5
- FWCI
- 343.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Genome Canada
- Genome Alberta
- Health Canada
- Canadian Institutes of Health Research
- National Human Genome Research Institute
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- DrugBank, drug databases, drug-drug interactions, food-drug interactions, therapeutic target, drug mechanisms, drug indications, pharmacometabolomics, pharmacoproteomics, drug repurposing, clinical trials, investigational drugs
- MeSH terms
- Drug Interactions, User-Computer Interface, Food-Drug Interactions, Polymorphism, Single Nucleotide, Metabolome, Transcriptome, Databases, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

